Aveanna (AVAH) 8-K: furnishes Q3 and nine-month results for 9/27/2025

Aveanna Healthcare Holdings Inc. (AVAH) furnished an 8-K announcing it issued a press release with financial results for the three and nine-month periods ended September 27, 2025.

Rhea-AI Filing Summary

Aveanna Healthcare Holdings Inc. (AVAH) furnished an 8-K announcing it issued a press release with financial results for the three and nine-month periods ended September 27, 2025. The press release is provided as Exhibit 99.1 and relates to Item 2.02 (Results of Operations and Financial Condition), with related information also referenced under Item 7.01 (Regulation FD).

The company states the information in this report, including Exhibit 99.1, is “furnished” and not “filed,” which means it is not subject to Section 18 liabilities and will only be incorporated by reference in other filings if specifically stated. The filing is signed by the Chief Accounting Officer as of November 6, 2025.

8-K Event Classification

Item 2.02 — Results of Operations and Financial Condition

1 item

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Aveanna (AVAH) announce in this 8-K?

Aveanna furnished a press release (Exhibit 99.1) announcing financial results for the three and nine-month periods ended September 27, 2025.

Which reporting items are included in the 8-K for AVAH?

Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).

Are the results in the 8-K considered filed or furnished?

They are “furnished” and not “filed,” and are not subject to Section 18 of the Exchange Act.

What exhibit contains the results for Aveanna (AVAH)?

Exhibit 99.1 is the press release dated November 6, 2025 with the company’s financial results.

What periods do the results cover for AVAH?

The three and nine-month periods ended September 27, 2025.

Who signed the 8-K for Aveanna?

Deborah Stewart, Chief Accounting Officer (Principal Accounting Officer), signed the report as of November 6, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/06/2025 - 06:30 AM Learn about SEC filing dates

0001832332false00018323322025-11-062025-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 6, 2025

Aveanna Healthcare Holdings Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware	001-40362	81-4717209
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

400 Interstate North Parkway SE, Atlanta, Georgia (Address of Principal Executive Offices) 30339 (Zip Code)

(770)-441-1580

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.01 per share		AVAH		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On November 6, 2025, Aveanna Healthcare Holdings Inc., a Delaware corporation (“we,” “us,” “our” or the “Company”), issued a press release announcing its financial results for the three and nine-month periods ended September 27, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 2.02.

Item 7.01 Regulation FD Disclosure.

The information contained in Item 2.02 of this Current Report on Form 8-K is incorporated by reference in this Item 7.01.

The information contained in this Current Report on Form 8-K, including in Exhibit 99.1 attached hereto, is “furnished” and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, except to the extent such other filing specifically incorporates such information by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Press Release dated November 6, 2025 announcing the Company’s financial results for the three and nine-month periods ended September 27, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		AVEANNA HEALTHCARE HOLDINGS INC.
Date: November 6, 2025		By:	/s/ Deborah Stewart
			Deborah Stewart
			Chief Accounting Officer (Principal Accounting Officer)